Hot Versus Hot: AVX Corporation (NYSE:AVX), Viveve Medical, Inc. (NASDAQ:VIVE)

AVX Corporation (NYSE:AVX)

AVX Corporation (NYSE:AVX) closed at $18.11 on the last trading session with an increase of 0.17%, whereas, it previously closed at $18.08. The company has a market capitalization of $3.05 Billion. The company traded shares of 330786 on the trading day while its three month average volume stands at 266.77 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of AVX Corporation (NYSE:AVX) produced diluted EPS of 1.38. The EPS estimate for next year as estimated by analysts is at 1.5 while EPS for next quarter is estimated at 0.39. Earnings per Share growth for this year is reported at 5.1, while the analysts estimated the EPS growth for next year at 1.5% and Earnings growth for next 5 years stands at 8.6% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 32.4%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of AVX Corporation (NYSE:AVX) is at 13.11 while the forward p/e is at 12.07. The P/S or Price to Sales ratio of AVX Corporation (NYSE:AVX) stands at 1.7 and Price to Book or P/B for the most recent quarter stands at 1.31. The Price to Free Cash Flow ratio or P/FCF is reported at 124.63. The quick ratio and the current ratio of AVX Corporation (NYSE:AVX) are reported at 3.9 and 5.8 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for AVX Corporation (NYSE:AVX) stands at 8.6, 10.3 and 5.4 respectively

The trailing twelve month Revenue of AVX Corporation (NYSE:AVX) is reported at 1.8 Billion with income of 234.1 Million. The outstanding shares of AVX Corporation (NYSE:AVX) are 168.61 Million. The institutional Ownership of the shares of 26.4 stands at 0.80%, this figure is decreased -0.18 in the last six months. The insider ownership for the shares of AVX Corporation (NYSE:AVX) is ticked at 72.25%, the figure is plummeted -0.01% in the last six months.

Some other important financial aspects to be discussed here for AVX Corporation (NYSE:AVX) is the Mean Target Price estimated by the analysts which stands at 18. The 52 week high of AVX Corporation (NYSE:AVX) is placed at 21.48 and 52 week low is standing at 14.21.

Performance wise the shares of AVX Corporation (NYSE:AVX) rose up 3.13% for the week, it also rise 0.17% for the monthly performance, while for the quarter it went down 16.02%. The shares decrease -6.79% for the half year and flew up for the Year-To-Date performance. The shares of AVX Corporation (NYSE:AVX) grew 1.4% for the yearly performance.

Viveve Medical, Inc. (NASDAQ:VIVE)

Viveve Medical, Inc. (NASDAQ:VIVE) closed at $0.87 on the last trading session with an decrease of -2.95%, whereas, it previously closed at $0.9. The company has a market capitalization of $39.91 Million. The company traded shares of 167801 on the trading day while its three month average volume stands at 205.56 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Viveve Medical, Inc. (NASDAQ:VIVE) produced diluted EPS of -1.77. The EPS estimate for next year as estimated by analysts is at -0.84 while EPS for next quarter is estimated at -0.35. Earnings per Share growth for this year is reported at 3.1, while the analysts estimated the EPS growth for next year at -0.84% and Earnings growth for next 5 years stands at 20% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 60.3%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Viveve Medical, Inc. (NASDAQ:VIVE) is at 0 while the forward p/e is at 0. The P/S or Price to Sales ratio of Viveve Medical, Inc. (NASDAQ:VIVE) stands at 2.09 and Price to Book or P/B for the most recent quarter stands at 0. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of Viveve Medical, Inc. (NASDAQ:VIVE) are reported at 3.2 and 3.7 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Viveve Medical, Inc. (NASDAQ:VIVE) stands at -105, -838.2 and 0 respectively

The trailing twelve month Revenue of Viveve Medical, Inc. (NASDAQ:VIVE) is reported at 19.1 Million with income of -46700000. The outstanding shares of Viveve Medical, Inc. (NASDAQ:VIVE) are 45.64 Million. The institutional Ownership of the shares of 70.8 stands at 0.80%, this figure is increased 50.35 in the last six months. The insider ownership for the shares of Viveve Medical, Inc. (NASDAQ:VIVE) is ticked at 0.9%, the figure is rose 0% in the last six months.

Some other important financial aspects to be discussed here for Viveve Medical, Inc. (NASDAQ:VIVE) is the Mean Target Price estimated by the analysts which stands at 3.75. The 52 week high of Viveve Medical, Inc. (NASDAQ:VIVE) is placed at 4.34 and 52 week low is standing at 0.90.

Performance wise the shares of Viveve Medical, Inc. (NASDAQ:VIVE) fell down -4.92% for the week, it also fell -17.5% for the monthly performance, while for the quarter it went up -38.42%. The shares decrease -72.59% for the half year and plummeted for the Year-To-Date performance. The shares of Viveve Medical, Inc. (NASDAQ:VIVE) shrinked -79.42% for the yearly performance.

You may missed